UPDATE 1-EMA committee conditionally approves AbbVie leukaemia drug
October 14, 2016 at 09:10 AM EDT
Oct 14 (Reuters) - AbbVie Inc won the conditional backing of an advisory committee of the European Medicines Agency (EMA) on Friday for a drug to treat a form of blood cancer.
